Cannabis vs. COVID: What the research is showing

Published: Jan. 19, 2022, 9:10 a.m.

A study last week from two Oregon universities has generated a lot of buzz, after findings suggested that some cannabis compounds may be able to block the SARS-CoV-2 virus from entering human cells.\n\nIt adds to a growing body of research on cannabis and the coronavirus, as studies from around the world \u2014 including from Canada \u2014 have found that the cannabis compound CBD may be effective in helping treat some of the virus\u2019s most deadly symptoms.\n\nToday, Katie MacBride, a health science reporter at the online magazine Inverse, joins us for a deep dive into what the research says \u2014 and doesn\u2019t say \u2014 about cannabis and COVID-19.\n\nCORRECTION: This episode misstated that mRNA vaccines are designed to attach to the SARS-CoV-2 spike protein. To be clear, mRNA vaccines instruct the body's cells to make harmless copies of the spike protein, causing the body to produce antibodies which then attach to the proteins.